Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03493945
Title Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, ALT-803 and Epacadostat (QuEST1).
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

prostate cancer

Advanced Solid Tumor


ALT-803 + Epacadostat + FPV-Brachyury + M7824 + MVA-BN-Brachyury

FPV-Brachyury + M7824 + MVA-BN-Brachyury

ALT-803 + FPV-Brachyury + M7824 + MVA-BN-Brachyury

ALT-803 + M7824

Age Groups:
Covered Countries USA

No variant requirements are available.